Healio spoke with Ajay K. Nooka, MD, MPH, FACP, associate professor of hematology and medical oncology at Emory School of Medicine, about the need to reach underserved communities, identification of additional novel targets like GPRC5D and improvement in combination treatments with immunotherapies.